Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Life Metabolism|January 28, 2025
Type 2 diabetes originated from non-alcoholic fatty liver diseaseXuelian Xiong, Xiaoying LiClinics and Research in Hepatology and Gastroenterology|November 6, 2023
Applying proteomics in metabolic dysfunction-associated steatotic liver disease: From mechanism to biomarkersXiaofu Zhang, Xiaoying Li, Xuelian XiongFrontiers in Genetics|May 13, 2022
Identification of Hub Genes Associated With Non-alcoholic Steatohepatitis Using Integrated Bioinformatics AnalysisQingnan Meng, Xiaoying Li, Xuelian XiongFrontiers in Endocrinology|March 27, 2023
Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiologyJiahui Zhao, Hongyan Lei, Tianyi Wang, et al.Nutrition Research (New York, N.Y.)|August 31, 2025
Dietary vitamin E intake is associated with lower mortality among individuals with metabolic dysfunction-associated steatotic liver diseaseYajie Peng, Wanhong Wu, Lin Chen, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2020
Helicobacter pylori infection and the prevalence of hypertension in Chinese adults: The Dongfeng-Tongji cohortXuelian Xiong, Jun Chen, Meian He, et al.Diabetes|December 10, 2016
Aberrant Expression of FBXO2 Disrupts Glucose Homeostasis Through Ubiquitin-Mediated Degradation of Insulin Receptor in Obese MiceBin Liu, Han Lu, Duanzhuo Li, et al.Hepatology (Baltimore, Md.)|March 20, 2023
Parathyroid hormone receptor-1 signaling aggravates hepatic fibrosis through upregulating cAMP response element-binding protein-like 2Ting Hong, Xuelian Xiong, Yaqiong Chen, et al.Biochemical and Biophysical Research Communications|August 23, 2011
DAX1 suppresses FXR transactivity as a novel co-repressorJin Li, Yan Lu, Ruya Liu, et al.Journal of Hepatology|December 17, 2013
Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging miceXuelian Xiong, Xiaolin Wang, Yan Lu, et al.Pageof 4